The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy

Author： Gharaee-Kermani Mehrnaz   Hu Biao   Phan Sem H   Gyetko Margaret R  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.6, 2008-06, pp. : 905-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis: A Potential Role for Stem Cells in the Lung Parenchyma and Implications for Therapy

By Gharaee-Kermani Mehrnaz   Gyetko Margaret   Hu Biao   Phan Sem  

Pharmaceutical Research, Vol. 24, Iss. 5, 2007-05 ,pp. : 819-841

Springer Publishing Company

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Targeting the endothelin pathway in the idiopathic pulmonary fibrosis: the role of bosentan

By Antoniu Sabina A  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1077-1084

Informa Healthcare

Access to resources Recommend Favorite

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.  

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite

Emerging drugs for idiopathic pulmonary fibrosis

By Selman Moiséés   Pardo Annie   Richeldi Luca   Cerri Stefania  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 341-362

Informa Healthcare

Access to resources Recommend Favorite